rs3768235
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003921.5(BCL10):c.638G>A(p.Gly213Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0591 in 1,613,906 control chromosomes in the GnomAD database, including 3,401 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_003921.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BCL10 | NM_003921.5 | c.638G>A | p.Gly213Glu | missense_variant | 3/3 | ENST00000648566.1 | NP_003912.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BCL10 | ENST00000648566.1 | c.638G>A | p.Gly213Glu | missense_variant | 3/3 | NM_003921.5 | ENSP00000498104.1 | |||
BCL10 | ENST00000620248.3 | c.605G>A | p.Gly202Glu | missense_variant | 3/3 | 5 | ENSP00000480561.2 | |||
BCL10 | ENST00000650582.1 | n.*38G>A | downstream_gene_variant |
Frequencies
GnomAD3 genomes AF: 0.0473 AC: 7199AN: 152162Hom.: 251 Cov.: 33
GnomAD3 exomes AF: 0.0651 AC: 16344AN: 251142Hom.: 680 AF XY: 0.0660 AC XY: 8954AN XY: 135760
GnomAD4 exome AF: 0.0603 AC: 88113AN: 1461626Hom.: 3151 Cov.: 31 AF XY: 0.0610 AC XY: 44361AN XY: 727126
GnomAD4 genome AF: 0.0473 AC: 7199AN: 152280Hom.: 250 Cov.: 33 AF XY: 0.0474 AC XY: 3530AN XY: 74460
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Immunodeficiency 37 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at